home All News open_in_new Full Article

Rakovina Therapeutics Congratulates Partner – Variational AI for Winning LifeSciencesBC’s 2025 Emerging Biotech Company of the Year Award

Award Recognition underscores the importance of AI-driven drug discovery VANCOUVER, British Columbia, July 11, 2025 (GLOBE NEWSWIRE) —  Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next-generation cancer therapies through AI-powered drug discovery proudly congratulates partner, Variational AI, on being honored as the 2025 Emerging Company of the Year […]


today 20 h. ago attach_file Economics

attach_file Economics
attach_file Other
attach_file Culture
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Science
attach_file Culture
attach_file Other


ID: 913284616
Add Watch Country

arrow_drop_down